Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar
Did you know?
What made us buy IEX@193, Tata Power@56, Titan@330, Divis@629, Persistent@700.

USFDA issues ‘DMF information request’ to SMS Pharmaceuticals

17 Sep 2019

US Food and Drug Administration (USFDA) has issued a ‘DMF information request’ to SMS Pharmaceuticals to provide the information to demonstrate its Ranitidine API manufacturing process does not contain NDMA impurity.

SMS Pharmaceuticals is a global player in API manufacturing having strong research and manufacturing team supported by state of art facilities.

Related SMS Pharmaceuticals Ltd. Links:

SMS Pharmaceuticals Share Price

131.00 1.80 (1.39%) Nov 26, 18:01
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 766.35
Cipla 966.15
Dr. Reddy's Lab 4744.90
Aurobindo Pharma 678.15
Lupin 915.35
View more..
Sensex vs SMS Pharmaceuticals
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback